INSM Insmed, Inc.

18.77
0  -2%
Previous Close 19.12
Open 19.12
Price To book 7.68
Market Cap 1.16B
Shares 62,023,000
Volume 316,689
Short Ratio 13.51
Av. Daily Volume 316,503

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 to be initiated 2017.
INS1007
Bronchiectasis
Phase 2 ready.
INS1009
Pulmonary arterial hypertension (PAH)
Phase 2 trial to be initiated in 2017.
AZD7986
Non-cystic fibrosis bronchiectasis
Phase 3 Euro data released 1 July 2013. Met endpoint but slighly inferior data to competition
ARIKAYCE
Cystic fibrosis
Phase 3 data due 2H 2017.
ARIKAYCE
Non-tuberculous Mycobacterial Lung Disease

Latest News

  1. Implied Volatility Surging for Insmed (INSM) Stock Options
  2. Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference
  3. Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017
  4. Do Options Traders Know Something About Insmed Incorporated (INSM) Stock We Don't?
  5. Insmed to Present at the Cowen and Company 37th Annual Health Care Conference
  6. Edited Transcript of INSM earnings conference call or presentation 23-Feb-17 1:30pm GMT
  7. Insmed reports 4Q loss
  8. Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update
  9. Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017
  10. Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
  11. Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc.
  12. Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight
  13. Insmed, Inc. :INSM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
  14. Edited Transcript of INSM earnings conference call or presentation 3-Nov-16 12:30pm GMT
  15. Insmed, Inc. :INSM-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
  16. SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
  17. INSM INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016
  18. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016